BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3345071)

  • 1. Prospective nerve conduction studies in cisplatin therapy.
    Riggs JE; Ashraf M; Snyder RD; Gutmann L
    Ann Neurol; 1988 Jan; 23(1):92-4. PubMed ID: 3345071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies.
    Krarup-Hansen A; Helweg-Larsen S; Schmalbruch H; Rørth M; Krarup C
    Brain; 2007 Apr; 130(Pt 4):1076-88. PubMed ID: 17301082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis.
    von Schlippe M; Fowler CJ; Harland SJ
    Br J Cancer; 2001 Sep; 85(6):823-6. PubMed ID: 11556831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of peripheral sensory fibers in amyotrophic lateral sclerosis: electrophysiological study of 64 cases.
    Mondelli M; Rossi A; Passero S; Guazzi GC
    Muscle Nerve; 1993 Feb; 16(2):166-72. PubMed ID: 8429840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in peripheral and central nerve conduction with aging.
    Mackenzie RA; Phillips LH
    Clin Exp Neurol; 1981; 18():109-16. PubMed ID: 6926379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The subclinical incidence of CTS in pregnancy: Assessment of median nerve impairment in asymptomatic pregnant women.
    Baumann F; Karlikaya G; Yuksel G; Citci B; Kose G; Tireli H
    Neurol Neurophysiol Neurosci; 2007 Aug; ():3. PubMed ID: 17700927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies.
    Chaudhry V; Rowinsky EK; Sartorius SE; Donehower RC; Cornblath DR
    Ann Neurol; 1994 Mar; 35(3):304-11. PubMed ID: 7907208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of nerve conduction parameters and serum magnesium following cisplatin therapy.
    Ashraf M; Riggs JE; Wearden S; Scotchel P
    Gynecol Oncol; 1990 Apr; 37(1):29-33. PubMed ID: 2157640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurophysiological changes in neurologically asymptomatic hypothyroid patients: a prospective cohort study.
    El-Salem K; Ammari F
    J Clin Neurophysiol; 2006 Dec; 23(6):568-72. PubMed ID: 17143145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large amplitude sensory action potentials in myelopathy: an observation.
    Pullman SL; Rubin M
    Muscle Nerve; 1991 Aug; 14(8):709-15. PubMed ID: 1890995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Superiority of intrafascicular neurography over conventional nerve conduction studies in evaluating axonal degeneration].
    Hasegawa O; Matsumoto S; Iino M; Kurita R; Yoshii T
    No To Shinkei; 1999 Apr; 51(4):313-6. PubMed ID: 10363265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve conduction studies in patients treated with cis-diamminedichloroplatinum(II): a preliminary report.
    Cowan JD; Kies MS; Roth JL; Joyce RP
    Cancer Treat Rep; 1980; 64(10-11):1119-22. PubMed ID: 7193088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of nerve conduction studies in myotonic dystrophy type 1: primary involvement of nerves or incidental coexistence?
    Bae JS; Kim OK; Kim SJ; Kim BJ
    J Clin Neurosci; 2008 Oct; 15(10):1120-4. PubMed ID: 18657426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facial nerve conduction in diabetic neuropathy.
    Irkeç C; Nazliel B; Yetkin I; Koçer B
    Acta Neurol Belg; 2001 Sep; 101(3):177-9. PubMed ID: 11817267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the latency difference between compound muscle and sensory nerve action potentials].
    Hasegawa O; Gondo G; Wada N; Matsumoto S; Mimura E
    No To Shinkei; 2001 Jun; 53(6):541-5. PubMed ID: 11436338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polyneuropathy index-revised in the evaluation of diabetic neuropathy].
    Hasegawa O; Matsumoto S; Gondo G; Arita T
    No To Shinkei; 2001 Mar; 53(3):259-63. PubMed ID: 11296400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and electrophysiological studies in vincristine induced neuropathy.
    Pal PK
    Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):323-30. PubMed ID: 10499201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration.
    Müller T; Renger K; Kuhn W
    Arch Neurol; 2004 May; 61(5):657-60. PubMed ID: 15148140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and electrophysiological evaluation of patients with thalidomide-induced neuropathy.
    Kocer B; Sucak G; Kuruoglu R; Aki Z; Haznedar R; Erdogmus NI
    Acta Neurol Belg; 2009 Jun; 109(2):120-6. PubMed ID: 19681443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical cranial nerve involvement in hereditary motor and sensory neuropathy: a combined conduction study with electrical and magnetic stimulation.
    Kumagai-Eto R; Kaseda Y; Tobimatsu S; Uozumi T; Tsuji S; Nakamura S
    Clin Neurophysiol; 2004 Jul; 115(7):1689-96. PubMed ID: 15203071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.